Angular Cheilitis Treatment - Cure Angular Cheilitis Today!

In order for an Angular Cheilitis treatment to work efficiently, directly and absolutely, it also should be simple, and have one focus of attack aimed at the root of the problem. For this to come about, we need to examine the main cause of Angular Cheilitis, and then we can formulate a proper treatment. To get right down to it, the primary active agent involved is fungal bacteria. It is this which infects the corners of the mouth, creating the lesions resembling infected paper cuts.

Inoperable Or Metastatic Tumors - Calando Pharmaceuticals Announces Completion Of IT-101 Phase 1 Clinical Study

Inoperable Or Metastatic Tumors - Calando Pharmaceuticals Announces Completion Of IT-101 Phase 1 Clinical Study
Calando Pharmaceuticals, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today completion of the IT-101 Phase I clinical study conducted at City of Hope in Duarte, California. The company expects the entire study data to be published in early 2009. IT-101 is an experimental, nanoparticle therapeutic that consists of the drug camptothecin (CPT) conjugated to a cyclodextrin polymer.

Cancer Drug Vidaza(R) Receives Positive Opinion From European Regulatory Authority For Treatment Of MDS And AML
The positive opinion includes important survival data from the AZA-001 trial in higher-risk MDS patients. The CHMP, which reviews applications for all 27 Member States in the European Union (EU) as well as Norway and Iceland, has recommended approval for azacitidine. The CHMP's positive opinion will be forwarded to the European Commission, which generally follows the recommendation of the CHMP and typically issues final marketing approval within two to three months.